Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Association between toll-like receptor expression and human papillomavirus type 16 persistence.

Daud II, Scott ME, Ma Y, Shiboski S, Farhat S, Moscicki AB.

Int J Cancer. 2011 Feb 15;128(4):879-86. doi: 10.1002/ijc.25400.

2.

Expression of nucleic acid-sensing Toll-like receptors predicts HPV16 clearance associated with an E6-directed cell-mediated response.

Scott ME, Ma Y, Farhat S, Moscicki AB.

Int J Cancer. 2015 May 15;136(10):2402-8. doi: 10.1002/ijc.29283. Epub 2014 Oct 30.

3.

Antagonist-mediated down-regulation of Toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus.

Yu SL, Chan PK, Wong CK, Szeto CC, Ho SC, So K, Yu MM, Yim SF, Cheung TH, Wong MC, Cheung JL, Yeung AC, Li EK, Tam LS.

Arthritis Res Ther. 2012 Apr 18;14(2):R80. doi: 10.1186/ar3803.

4.

Characterization of Toll-like receptor transcriptome in squamous cell carcinoma of cervix: A case-control study.

Aggarwal R, Misra S, Guleria C, Suri V, Mangat N, Sharma M, Nijhawan R, Minz R.

Gynecol Oncol. 2015 Aug;138(2):358-62. doi: 10.1016/j.ygyno.2015.05.029. Epub 2015 May 27.

PMID:
26024767
5.
6.

TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.

Hasan UA, Bates E, Takeshita F, Biliato A, Accardi R, Bouvard V, Mansour M, Vincent I, Gissmann L, Iftner T, Sideri M, Stubenrauch F, Tommasino M.

J Immunol. 2007 Mar 1;178(5):3186-97.

7.

TLR9 is expressed in human papillomavirus-positive cervical cells and is overexpressed in persistent infections.

Cannella F, Pierangeli A, Scagnolari C, Cacciotti G, Tranquilli G, Stentella P, Recine N, Antonelli G.

Immunobiology. 2015 Mar;220(3):363-8. doi: 10.1016/j.imbio.2014.10.012. Epub 2014 Oct 23.

PMID:
25454809
8.

Toll-like receptor transcriptome in the HPV-positive cervical cancer microenvironment.

DeCarlo CA, Rosa B, Jackson R, Niccoli S, Escott NG, Zehbe I.

Clin Dev Immunol. 2012;2012:785825. doi: 10.1155/2012/785825. Epub 2011 Oct 13.

9.

IFNs activate toll-like receptor gene expression in viral infections.

Miettinen M, Sareneva T, Julkunen I, Matikainen S.

Genes Immun. 2001 Oct;2(6):349-55.

10.

[Study on the expression and signification of TLR4/NO pathway in cervical tumorigenesis with high risk HPV infection].

Xiao J, Guo Q, Wang X, Xie F, Zhang H, Sui L.

Zhonghua Fu Chan Ke Za Zhi. 2015 Jan;50(1):41-7. Chinese.

PMID:
25877424
11.

Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection.

Lester RT, Yao XD, Ball TB, McKinnon LR, Kaul R, Wachihi C, Jaoko W, Plummer FA, Rosenthal KL.

AIDS. 2008 Mar 30;22(6):685-94. doi: 10.1097/QAD.0b013e3282f4de35.

PMID:
18356597
12.

Kinetics of DNA load predict HPV 16 viral clearance.

Marks M, Gravitt PE, Utaipat U, Gupta SB, Liaw K, Kim E, Tadesse A, Phongnarisorn C, Wootipoom V, Yuenyao P, Vipupinyo C, Rugpao S, Sriplienchan S, Celentano DD.

J Clin Virol. 2011 May;51(1):44-9. doi: 10.1016/j.jcv.2011.01.011. Epub 2011 Mar 9.

13.

Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: markers of immune response?

Siegel EM, Patel N, Lu B, Lee JH, Nyitray AG, Craft NE, Frenkel K, Villa LL, Franco EL, Giuliano AR.

Int J Cancer. 2012 Jul 1;131(1):219-28. doi: 10.1002/ijc.26363. Epub 2011 Nov 28.

14.

Correlates of cervical mucosal antibodies to human papillomavirus 16: results from a case control study.

Bierl C, Karem K, Poon AC, Swan D, Tortolero-Luna G, Follen M, Wideroff L, Unger ER, Reeves WC.

Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S262-8. Epub 2005 Oct 17.

PMID:
16229879
15.

Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions.

Yoshida T, Sano T, Kanuma T, Owada N, Sakurai S, Fukuda T, Nakajima T.

Int J Gynecol Cancer. 2008 Jan-Feb;18(1):121-7. Epub 2007 May 15.

PMID:
17506843
16.

HPV: from infection to cancer.

Stanley MA, Pett MR, Coleman N.

Biochem Soc Trans. 2007 Dec;35(Pt 6):1456-60. Review.

PMID:
18031245
17.

Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status.

Hublarova P, Hrstka R, Rotterova P, Rotter L, Coupkova M, Badal V, Nenutil R, Vojtesek B.

Int J Gynecol Cancer. 2009 Apr;19(3):321-5. doi: 10.1111/IGC.0b013e31819d8a5c.

PMID:
19407553
18.

Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.

Bellone S, El-Sahwi K, Cocco E, Casagrande F, Cargnelutti M, Palmieri M, Bignotti E, Romani C, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.

J Virol. 2009 Jul;83(13):6779-89. doi: 10.1128/JVI.02443-08. Epub 2009 Apr 22.

19.

Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.

de Boer MA, Jordanova ES, van Poelgeest MI, van den Akker BE, van der Burg SH, Kenter GG, Fleuren GJ.

Int J Cancer. 2007 Dec 15;121(12):2711-5.

20.

The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.

Domingues R, de Carvalho GC, da Silva Oliveira LM, Futata Taniguchi E, Zimbres JM, Aoki V, da Silva Duarte AJ, Sato MN.

Br J Dermatol. 2015 Jan;172(1):48-55. doi: 10.1111/bjd.13214. Epub 2014 Nov 20.

PMID:
24976336
Items per page

Supplemental Content

Write to the Help Desk